Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer

NCT07348887 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)

Interventions

RADIATION: Daily adaptive radiation therapy
RADIATION: Image guided radiation therapy

Sponsor

University Health Network, Toronto